Y. Aoki, T. Niihori, and H. Kawame, Germline mutations in HRAS proto-oncogene cause Costello syndrome, Nature Genetics, vol.400, issue.10, pp.1038-1078, 2005.
DOI : 10.1038/22780

9. Costello and J. , A new syndrome, N Z Med J, vol.74, p.397, 1971.

J. Costello, A New Syndrome: Mental Subnormality and Nasal Papillomata, Journal of Paediatrics and Child Health, vol.14, issue.2, pp.114-122, 1977.
DOI : 10.1016/S0031-3955(16)32065-X

R. Martin and K. Jones, Delineation of the costello syndrome, American Journal of Medical Genetics, vol.13, issue.3, pp.41346-41355, 1991.
DOI : 10.1002/ajmg.1320410316

Z. Borochowitz, L. Pavone, and G. Mazor, New multiple congenital anomalies: Mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement, American Journal of Medical Genetics, vol.33, issue.4, pp.678-85, 1992.
DOI : 10.1016/S0031-3955(16)36297-6

D. Kaloustian, V. Moroz, B. Mcintosh, and N. , Costello syndrome, American Journal of Medical Genetics, vol.25, issue.1, pp.69-73, 1991.
DOI : 10.1002/ajmg.1320410118

E. Izumikawa, Y. Naritomi, K. Tohma, and T. , The costello syndrome: A boy with thick mitral valves and arrhythmias, The Japanese Journal of Human Genetics, vol.38, issue.3, pp.329-363, 1993.
DOI : 10.1007/BF01874143

!. Lin, A. Grossfeld, P. Hamilton, and R. , Further delineation of cardiac abnormalities in Costello syndrome, American Journal of Medical Genetics, vol.47, issue.2, pp.115-144, 2002.
DOI : 10.1002/ajmg.1320470210

T. Fukao, S. Sakai, and N. Shimozawa, Life-threatening cardiac involvement throughout life in a case of Costello syndrome, Clinical Genetics, vol.47, issue.4, pp.244-251, 1996.
DOI : 10.1111/j.1399-0004.1996.tb02636.x

I. Moroni, F. Bedeschi, and R. Luksch, Costello Syndrome: a cancer predisposing syndrome?, Clinical Dysmorphology, vol.9, issue.4, pp.265-273, 2000.
DOI : 10.1097/00019605-200009040-00006

G. Zampino, P. Mastroiacovo, and R. Ricci, Costello syndrome: Further clinical delineation, natural history, genetic definition, and nosology, American Journal of Medical Genetics, vol.38, issue.2, pp.47176-83, 1993.
DOI : 10.1097/00007611-197708000-00031

Z. Borochowitz, L. Pavone, and G. Mazor, New multiple congenital anomalies: Mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement, American Journal of Medical Genetics, vol.33, issue.4, pp.678-85, 1992.
DOI : 10.1016/S0031-3955(16)36297-6

I. Lurie, Genetics of the Costello syndrome, American Journal of Medical Genetics, vol.47, issue.3, pp.358-367, 1994.
DOI : 10.1002/ajmg.1320520321

T. Van-den-bosch, V. Schoubroeck, D. Fryns, and J. , Prenatal findings in a monozygotic twin pregnancy with Costello syndrome, Prenatal Diagnosis, vol.6, issue.5, pp.415-422, 2002.
DOI : 10.1002/pd.333

A. Czeizel and L. Tímár, Hungarian case with Costello syndrome and translocation t(1,22), American Journal of Medical Genetics, vol.47, issue.3, p.22
DOI : 10.1002/ajmg.1320570331

P. Franceschini, D. Licata, D. Cara, and G. , Bladder carcinoma in Costello syndrome: Report on a patient born to consanguineous parents and review, American Journal of Medical Genetics, vol.47, issue.2, pp.174-183, 1999.
DOI : 10.1002/(SICI)1096-8628(19990910)86:2<174::AID-AJMG17>3.0.CO;2-Y

K. Gripp, C. Scott, . Jr, and L. Nicholson, Second case of bladder carcinoma in a patient with Costello syndrome, American Journal of Medical Genetics, vol.86, issue.3, pp.90256-90265, 2000.
DOI : 10.1002/(SICI)1096-8628(19990910)86:2<174::AID-AJMG17>3.0.CO;2-Y

M. Suri and C. Garrett, Costello syndrome with acoustic neuroma and cataract. Is the Costello locus linked to neurofibromatosis type 2 on 22q?, Clinical Dysmorphology, vol.7, issue.2, pp.149-51, 1998.
DOI : 10.1097/00019605-199804000-00014

B. Kerr, O. Eden, and R. Dandamudi, Costello syndrome: two cases with embryonal rhabdomyosarcoma., Journal of Medical Genetics, vol.35, issue.12, pp.351036-351045, 1998.
DOI : 10.1136/jmg.35.12.1036

URL : http://jmg.bmj.com/content/jmedgenet/35/12/1036.full.pdf

K. Gripp, C. Scott, . Jr, and L. Nicholson, Five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol, American Journal of Medical Genetics, vol.47, issue.Suppl A37, pp.80-87, 2002.
DOI : 10.1002/ajmg.1320470210

B. Kerr, M. Mucchielli, and S. Sigaudy, Is the locus for Costello syndrome on 11p?, Journal of Medical Genetics, vol.40, issue.6, pp.40469-71, 2003.
DOI : 10.1136/jmg.40.6.469

D. Kaloustian and V. , Not a new MCA/MR syndrome but probably Costello syndrome?, American Journal of Medical Genetics, vol.41, issue.2
DOI : 10.1002/ajmg.1320470206

M. Tartaglia, P. Cotter, and G. Zampino, Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes, Clinical Genetics, vol.9, issue.5, pp.63423-63429, 2003.
DOI : 10.1016/S0962-8924(99)01668-2

A. Estep, W. Tidyman, and M. Teitell, HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy, American Journal of Medical Genetics Part A, vol.47, issue.1, pp.1408-1424, 2006.
DOI : 10.1002/ajmg.c.30065

K. Gripp, A. Lin, and D. Stabley, HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation, American Journal of Medical Genetics Part A, vol.67, issue.1, pp.1-7, 2006.
DOI : 10.1016/S0027-5107(00)00022-1

J. Fryns, H. Devlieger, and M. Gewillig, Polyhydramnios and paroxysmal atrial tachycardia as first clinical signs in Costello syndrome, Genet Couns, vol.7, issue.3, pp.237-246, 1996.

A. Lin, O. Brien, B. Demmer, and L. , Prenatal features of Costello syndrome: ultrasonographic findings and atrial tachycardia, Prenatal Diagnosis, vol.28, issue.7, pp.29682-90, 2009.
DOI : 10.1111/j.1442-200X.1998.tb02000.x

L. Smith, J. Podraza, and V. Proud, Polyhydramnios, fetal overgrowth, and macrocephaly: Prenatal ultrasound findings of Costello syndrome, American Journal of Medical Genetics Part A, vol.136, issue.4, pp.149-779, 2009.
DOI : 10.1016/0002-9378(91)90290-8

N. Philip, S. Sigaudy, and . Costello-syndrome, Costello syndrome., Journal of Medical Genetics, vol.35, issue.3, pp.238-278, 1998.
DOI : 10.1136/jmg.35.3.238

K. Gripp, A. Innes, and M. Axelrad, Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?, Am J Med Genet A, issue.6, pp.146-683, 2008.
DOI : 10.1002/ajmg.a.32227

S. White, J. Graham, . Jr, and B. Kerr, The adult phenotype in Costello syndrome, American Journal of Medical Genetics Part A, vol.47, issue.2, pp.128-163, 2005.
DOI : 10.1002/ajmg.a.30747

R. Hennekam, Costello syndrome: An overview, American Journal of Medical Genetics, vol.47, issue.1, pp.42-50, 2003.
DOI : 10.1002/ajmg.1320470210

A. Torrelo, A. López-avila, and I. Mediero, Costello syndrome, Journal of the American Academy of Dermatology, vol.32, issue.5, pp.904-911, 1995.
DOI : 10.1016/0190-9622(95)91559-1

M. Mori, T. Yamagata, and Y. Mori, Elastic fiber degeneration in Costello syndrome, American Journal of Medical Genetics, vol.47, issue.4, pp.304-313, 1996.
DOI : 10.1002/ajmg.1320470210

M. Boente, R. Carrero-valenzuela, and M. Frontini, Costello syndrome: report of a new case with choanal atresia and fatal outcome, Eur J Dermatol, vol.11, issue.5, pp.453-460, 2001.

V. Torres, J. , P. Marfa, M. , G. Enseñat et al., Pathology of the elastic tissue of the skin in Costello syndrome. An image analysis study using mathematical morphology, Anal Quant Cytol Histol, issue.6, pp.16421-16430, 1994.

M. Nasca, L. Strano, and M. Musumeci, What syndrome is this? Costello syndrome

R. Yoshida, Y. Fukushima, and H. Ohashi, The Costello syndrome: Are nasal papillomata essential?, The Japanese Journal of Human Genetics, vol.41, issue.4, pp.437-481, 1993.
DOI : 10.1007/BF01907992

D. Rocco, M. Gatti, R. Gandullia, and P. , Report on two patients with Costello syndrome and sialuria, American Journal of Medical Genetics, vol.41, issue.7, pp.471135-471175, 1993.
DOI : 10.1002/ajmg.1320470737

R. Pratesi, M. Santos, and I. Ferrari, Costello syndrome in two Brazilian children., Journal of Medical Genetics, vol.35, issue.1, pp.54-61, 1998.
DOI : 10.1136/jmg.35.1.54

J. Fryns, A. Vogels, and J. Haegeman, Costello syndrome: a postnatal growth retardation syndrome with distinct phenotype, Genet Couns, vol.5, issue.4, pp.337-380, 1994.

N. Philip and J. Mancini, Costello syndrome and facio-cutaneous-skeletal syndrome, American Journal of Medical Genetics, vol.41, issue.2, pp.174-179, 1993.
DOI : 10.1002/ajmg.1320470209

J. Johnson, M. Golabi, and M. Norton, Costello syndrome: Phenotype, natural history, differential diagnosis, and possible cause, The Journal of Pediatrics, vol.133, issue.3, pp.441-449, 1998.
DOI : 10.1016/S0022-3476(98)70284-7

S. Davies and H. Hughes, Costello syndrome: natural history and differential diagnosis of cutis laxa., Journal of Medical Genetics, vol.31, issue.6, pp.31486-31495, 1994.
DOI : 10.1136/jmg.31.6.486

M. Popa, D. Ioan, and J. Fryns, Costello syndrome: report of an 8-month-old marasmic boy

M. Patton and M. Baraitser, Cutis laxa and the Costello syndrome., Journal of Medical Genetics, vol.30, issue.7, p.622, 1993.
DOI : 10.1136/jmg.30.7.622

S. Szalai, K. Becker, and E. Török, Costello syndrome with decreased glucose tolerance, Eur J Dermatol, issue.97, pp.533-539, 1999.

A. Lin, M. Alexander, and S. Colan, Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras/MAPK pathway syndrome, American Journal of Medical Genetics Part A, vol.286, issue.3, 2011.
DOI : 10.1152/ajpheart.00110.2003

B. Maron, W. Mckenna, and G. Danielson, American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines, European Heart Journal, vol.24, issue.21, pp.421687-713, 2003.
DOI : 10.1016/S0195-668X(03)00479-2

H. Dodo, R. Gow, and R. Hamilton, Chaotic atrial rhythm in children, American Heart Journal, vol.129, issue.5, pp.990-995, 1995.
DOI : 10.1016/0002-8703(95)90121-3

J. Wang, J. Wu, and Y. Tsai, Ectopic atrial tachycardia in children, J Formos Med Assoc, issue.10, pp.99766-70, 2000.

A. Hinek, M. Teitell, and L. Schoyer, Myocardial storage of chondroitin sulfatecontaining moieties in Costello syndrome patients with severe hypertrophic cardiomyopathy

B. Kerr, M. Delrue, and S. Sigaudy, Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases, Journal of Medical Genetics, vol.43, issue.5, pp.43401-43406, 2006.
DOI : 10.1136/jmg.2005.040352

H. Kawame, M. Matsui, and K. Kurosawa, Further delineation of the behavioral and neurologic features in Costello syndrome, American Journal of Medical Genetics, vol.47, issue.1, pp.118-126, 2003.
DOI : 10.1002/ajmg.1320470210

M. Delrue, J. Chateil, and B. Arveiler, Costello syndrome and neurological abnormalities, American Journal of Medical Genetics, vol.47, issue.3, pp.123-301, 2003.
DOI : 10.1002/ajmg.a.20330

URL : http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.20330/pdf

Y. Fujikawa, K. Sugai, and M. Fukumizu, Three cases of Costello syndrome presenting with intractable epilepsy and profound psychomotor retardation/regression, No To Hattatsu, vol.33, issue.5, pp.430-435, 2001.

B. Say, !. M. Güçsava, and H. Morgan, The Costello syndrome, American Journal of Medical Genetics, vol.41, issue.2, pp.163-168, 1993.
DOI : 10.1002/ajmg.1320470203

M. Axelrad, D. Schwartz, and J. Fehlis, Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome, American Journal of Medical Genetics Part A, vol.28, issue.12, pp.149-2666, 2009.
DOI : 10.1007/978-1-4615-5369-4_9

C. Galéra, M. Delrue, and C. Goizet, Behavioral and temperamental features of children with Costello syndrome, American Journal of Medical Genetics Part A, vol.159, issue.9, pp.968-74, 2006.
DOI : 10.1002/ajmg.a.31169

K. Gripp, Tumor predisposition in Costello syndrome, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.47, issue.1, pp.72-79, 2005.
DOI : 10.1016/S0002-9440(10)63103-3

Y. Aoki, T. Niihori, and Y. Narumi, The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders, Human Mutation, vol.268, issue.8, pp.29992-1006, 2008.
DOI : 10.1136/jmg.36.10.799

A. Jebar, C. Hurst, and D. Tomlinson, FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma, Oncogene, vol.24, issue.33, pp.245218-245243, 2005.
DOI : 10.1073/pnas.87.22.9047

S. Schubbert, K. Shannon, and G. Bollag, Hyperactive Ras in developmental disorders and cancer, Nature Reviews Cancer, vol.91, issue.4, pp.295-308, 2007.
DOI : 10.1002/ajmg.a.31047

C. Tabin, S. Bradley, and C. Bargmann, Mechanism of activation of a human oncogene, Nature, vol.16, issue.5888, pp.300143-300152, 1982.
DOI : 10.1038/300143a0

E. Reddy, R. Reynolds, and E. Santos, A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene, Nature, vol.74, issue.5888, pp.300149-52, 1982.
DOI : 10.1038/300149a0

J. Downward, Targeting RAS signalling pathways in cancer therapy, Nature Reviews Cancer, vol.61, issue.1, pp.11-22, 2003.
DOI : 10.1038/356397a0

M. Cakir, C. Arici, and S. Tacoy, A case of Costello with parathyroid adenoma and hyperprolactinemia, American Journal of Medical Genetics, vol.82, issue.2, pp.124-196, 2004.
DOI : 10.1002/ajmg.a.20361

C. Kratz, S. Rapisuwon, and H. Reed, Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.72, issue.2, pp.83-92, 2011.
DOI : 10.1159/000243782

M. Malumbres and M. Barbacid, RAS oncogenes: The first 30 years, Nature Reviews Cancer, vol.245, issue.9, pp.459-65, 2003.
DOI : 10.1126/science.2569235

G. Johnson and R. Lapadat, Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases, Science, vol.298, issue.5600, pp.2981911-2981913, 2002.
DOI : 10.1126/science.1072682

K. Wennerberg, K. Rossman, and C. Der, The Ras superfamily at a glance, Journal of Cell Science, vol.118, issue.5, pp.843-849, 2005.
DOI : 10.1242/jcs.01660

J. Selcher, C. Atkins, and J. Trzaskos, A Necessity for MAP Kinase Activation in Mammalian Spatial Learning, Learning & Memory, vol.6, issue.5, pp.478-90, 1999.
DOI : 10.1101/lm.6.5.478

E. Johnson, L. Greenbaum, D. Cichowski, and K. , K-ras is an essential gene in the mouse with partial functional overlap with??N-ras, Genes & Development, vol.11, issue.19, pp.2468-81, 1997.
DOI : 10.1101/gad.11.19.2468

N. Mitin, K. Rossman, and C. Der, Signaling Interplay in Ras Superfamily Function, Current Biology, vol.15, issue.14, pp.563-74, 2005.
DOI : 10.1016/j.cub.2005.07.010

L. Buday and J. Downward, Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor, Cell, vol.73, issue.3, pp.73611-73631, 1993.
DOI : 10.1016/0092-8674(93)90146-H

A. Sasaki, T. Taketomi, and R. Kato, Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1, Cell Cycle, vol.2, issue.4, pp.281-283, 2003.
DOI : 10.4161/cc.2.4.418

URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.2.4.418?needAccess=true

T. Wakioka, A. Sasaki, and R. Kato, Spred is a Sprouty-related suppressor of Ras signalling, Nature, issue.6847, pp.412647-51, 2001.

M. Van-steensel, M. Vreeburg, and C. Peels, Recurring HRAS mutation G12S in Dutch patients with Costello syndrome, Experimental Dermatology, vol.5, issue.9, pp.731-735, 2006.
DOI : 10.1517/13543784.12.6.943

G. Zampino, F. Pantaleoni, and C. Carta, missense changes in Costello syndrome, Human Mutation, vol.340, issue.3, pp.265-72, 2007.
DOI : 10.1016/S0027-5107(00)00022-1

E. Denayer, A. Parret, and M. Chmara, p.Lys117Arg mutation, Human Mutation, vol.28, issue.2, pp.232-241, 2008.
DOI : 10.1002/ajmg.a.31047

A. Schulz, A. B. Arici, and C. , Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome, Clinical Genetics, vol.140, issue.15, pp.62-70, 2008.
DOI : 10.1002/ajmg.a.31315

K. Sol-church, D. Stabley, and L. Demmer, Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism

K. Sol-church, D. Stabley, and L. Nicholson, Paternal bias in parental origin of HRAS mutations in Costello syndrome, Hum Mutat, issue.8, pp.27736-27777, 2006.

N. Bodkin, E. Mortimer, and D. La, Male-to-male transmission of Costello syndrome consistent with autosomal dominant inheritance, Am J Hum Genet, vol.65, p.143, 1999.

K. Gripp, D. Stabley, and L. Nicholson, Somatic mosaicism for an HRAS mutation causes Costello syndrome, Am J Med Genet A, issue.20, pp.1402163-1402172, 2006.

K. Girisha, L. Lewis, and S. Phadke, Costello syndrome with severe cutis laxa and mosaic HRAS G12S mutation, American Journal of Medical Genetics Part A, vol.149, issue.11, pp.152-2861, 2010.
DOI : 10.1002/ajmg.a.33687

K. Gripp, E. Hopkins, and K. Sol-church, Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C, American Journal of Medical Genetics Part A, vol.28, issue.4, 2011.
DOI : 10.1002/humu.20431

L. Gremer, D. Luca, A. Merbitz-zahradnik, and T. , Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation, Human Molecular Genetics, vol.417, issue.5, pp.19790-802, 2010.
DOI : 10.1042/BJ20081535

A. Hinek, A. Smith, and E. Cutiongco, Decreased Elastin Deposition and High Proliferation of Fibroblasts from Costello Syndrome Are Related to Functional Deficiency in the 67-kD Elastin-Binding Protein, The American Journal of Human Genetics, vol.66, issue.3, pp.66859-72, 2000.
DOI : 10.1086/302829

A. Hinek, K. Braun, and K. Liu, Retrovirally Mediated Overexpression of Versican V3 Reverses Impaired Elastogenesis and Heightened Proliferation Exhibited by Fibroblasts from Costello Syndrome and Hurler Disease Patients, The American Journal of Pathology, vol.164, issue.1, pp.119-150, 2004.
DOI : 10.1016/S0002-9440(10)63103-3

J. Hurle, G. Corson, and K. Daniels, Elastin exhibits a distinctive temporal and spatial pattern of distribution in the developing chick limb in association with the establishment of the cartilaginous skeleton, J Cell Sci, pp.1072623-1072657, 1994.

K. Rauen, E. Hefner, and K. Carrillo, Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium, Am J Med Genet A, issue.9, pp.146-1205, 2007.

A. Hatamochi, H. Nagayama, and K. Kuroda, Costello Syndrome with Decreased Gene Expression of Elastin in Cultured Dermal Fibroblasts, Dermatology, vol.201, issue.4, pp.366-375, 2000.
DOI : 10.1159/000051558

Y. Tatano, R. Fujinawa, and Y. Kozutsumi, Tropoelastin regulates chemokine expression in fibroblasts in Costello syndrome, Biochemical and Biophysical Research Communications, vol.372, issue.4, pp.681-688, 2008.
DOI : 10.1016/j.bbrc.2008.05.131

T. Wight, Versican: a versatile extracellular matrix proteoglycan in cell biology, Current Opinion in Cell Biology, vol.14, issue.5, pp.617-640, 2002.
DOI : 10.1016/S0955-0674(02)00375-7

G. Rosenberger, S. Meien, and K. Kutsche, mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome, Human Mutation, vol.28, issue.Pt 24, pp.352-62, 2009.
DOI : 10.1172/JCI200420317

P. Rodriguez-viciana, P. Warne, and R. Dhand, Phosphatidylinositol-3-OH kinase direct target of Ras, Nature, vol.370, issue.6490, pp.527-559, 1994.
DOI : 10.1038/370527a0

E. Deutsch and F. Huguet, Perspectives in biological modulation of radiotherapy, Bull Cancer, vol.92, issue.1, pp.90-96, 2005.

1. Rodriguez-viciana, P. Warne, P. Khwaja, and A. , Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras, Cell, vol.89, issue.3, pp.89457-67, 1997.
DOI : 10.1016/S0092-8674(00)80226-3

1. Hopkins, E. Lin, A. Krepkovich, and K. , Living with Costello syndrome: Quality of life issues in older individuals, American Journal of Medical Genetics Part A, vol.136, issue.1, pp.152-84, 2010.
DOI : 10.1002/ajmg.a.30747

K. Gripp, H. Kawame, and D. Viskochil, Elevated catecholamine metabolites in patients with Costello syndrome, American Journal of Medical Genetics, vol.47, issue.1, pp.128-176, 2004.
DOI : 10.1002/ajmg.a.30100

M. Bentires-alj, M. Kontaridis, and B. Neel, Stops along the RAS pathway in human genetic disease, Nature Medicine, vol.439, issue.3, pp.283-288, 2006.
DOI : 10.1038/nature04304

Y. Narumi, Y. Aoki, and T. Niihori, Molecular and clinical characterization of cardiofacio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome, Am J Med Genet A, issue.8, pp.143-799, 2007.

C. Nava, N. Hanna, and C. Michot, Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype phenotype relationships and overlap with Costello syndrome, Journal of Medical Genetics, vol.44, issue.12, pp.44763-71, 2007.
DOI : 10.1136/jmg.2007.050450

M. Tartaglia, G. Zampino, and B. Gelb, Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis, Molecular Syndromology, vol.1, issue.1, pp.2-26, 2010.
DOI : 10.1159/000276766

URL : http://www.karger.com/Article/Pdf/276766

P. Hof, S. Pluskey, and S. Dhe-paganon, Crystal Structure of the Tyrosine Phosphatase SHP-2, Cell, vol.92, issue.4, pp.441-50, 1998.
DOI : 10.1016/S0092-8674(00)80938-1

M. Tartaglia, S. Martinelli, and L. Stella, Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease, The American Journal of Human Genetics, vol.78, issue.2, pp.279-90, 2006.
DOI : 10.1086/499925

M. Tartaglia, L. Pennacchio, and C. Zhao, Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome, Nature Genetics, vol.67, issue.1, pp.75-84, 2007.
DOI : 10.1136/adc.67.2.178

A. Roberts, T. Araki, and K. Swanson, Germline gain-of-function mutations in SOS1 cause Noonan syndrome, Nature Genetics, vol.6, issue.1, pp.70-74, 2007.
DOI : 10.1038/sj.gt.3300976

S. Schubbert, M. Zenker, and S. Rowe, Germline KRAS mutations cause Noonan syndrome, Nature Genetics, vol.2, issue.3, pp.331-337, 2006.
DOI : 10.1016/S1535-6108(02)00214-3

S. Schubbert, G. Bollag, and N. Lyubynska, Biochemical and Functional Characterization of Germ Line KRAS Mutations, Molecular and Cellular Biology, vol.27, issue.22, pp.277765-70, 2007.
DOI : 10.1128/MCB.00965-07

M. Razzaque, T. Nishizawa, and Y. Komoike, Germline gain-of-function mutations in RAF1 cause Noonan syndrome, Nature Genetics, vol.328, issue.8, pp.391013-391020, 2007.
DOI : 10.1002/aja.1002030302

A. Shaw, K. Kalidas, and A. Crosby, The natural history of Noonan syndrome: a long-term follow-up study, Archives of Disease in Childhood, vol.92, issue.2, pp.128-160, 2007.
DOI : 10.1136/adc.2006.104547

E. Legius, C. Schrander-stumpel, and E. Schollen, PTPN11 mutations in LEOPARD syndrome, Journal of Medical Genetics, vol.39, issue.8, pp.39571-39575, 2002.
DOI : 10.1136/jmg.39.8.571

M. Digilio, E. Conti, and A. Sarkozy, Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 Gene, The American Journal of Human Genetics, vol.71, issue.2, pp.71389-94, 2002.
DOI : 10.1086/341528

B. Pandit, A. Sarkozy, and L. Pennacchio, Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nature Genetics, vol.134, issue.8, pp.391007-391019, 2007.
DOI : 10.1002/ajmg.a.30603

M. Kontaridis, K. Swanson, and F. David, (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects, Journal of Biological Chemistry, vol.61, issue.10, pp.2816785-92, 2006.
DOI : 10.1128/MCB.24.12.5340-5352.2004

K. Oishi, H. Zhang, and W. Gault, Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development, Human Molecular Genetics, vol.10, issue.1
DOI : 10.1016/j.devcel.2006.02.004

A. Sarkozy, M. Digilio, and B. Dallapiccola, Leopard syndrome, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.13, 2008.
DOI : 10.1186/1750-1172-3-13

D. Voron, H. Hatfield, and R. Kalkhoff, Multiple lentigines syndrome, The American Journal of Medicine, vol.60, issue.3, pp.447-56, 1976.
DOI : 10.1016/0002-9343(76)90764-6

I. Kalev, K. Muru, and R. Teek, LEOPARD syndrome with recurrent PTPN11 mutation Y279C and different cutaneous manifestations: two case reports and a review of the literature, European Journal of Pediatrics, vol.8, issue.8, pp.469-73, 2010.
DOI : 10.1001/archpedi.1969.02100030654006

A. Sarkozy, E. Conti, and M. Digilio, Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome, Journal of Medical Genetics, vol.41, issue.5, pp.41-68, 2004.
DOI : 10.1136/jmg.2003.013466

P. Rodriguez-viciana, O. Tetsu, and W. Tidyman, Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome, Science, vol.311, issue.5765, pp.3111287-90, 2006.
DOI : 10.1126/science.1124642

T. Niihori, Y. Aoki, and Y. Narumi, Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome, Nature Genetics, vol.36, issue.3, pp.294-300, 2006.
DOI : 10.1136/jmg.36.10.799

P. Rodriguez-viciana and K. Rauen, Biochemical Characterization of Novel Germline BRAF and MEK Mutations in Cardio???Facio???Cutaneous Syndrome, Methods Enzymol, vol.438, pp.277-89, 2008.
DOI : 10.1016/S0076-6879(07)38019-1

D. Siegel, J. Mckenzie, and I. Frieden, Dermatological findings in 61 mutationpositive individuals with cardiofaciocutaneous syndrome, Br J Dermatol, vol.164, issue.3, pp.521-530, 2011.

Z. Csoma, Z. Erdei, and D. Bartusek, The prevalence of melanocytic naevi among teenagers, Orvosi Hetilap, vol.149, issue.46, pp.1492173-82, 2008.
DOI : 10.1556/OH.2008.28446

M. Terao, N. Sakai, and S. Higashiyama, Cutaneous symptoms in a patient with cardiofaciocutaneous syndrome and increased ERK phosphorylation in skin fibroblasts, British Journal of Dermatology, vol.19, issue.4, pp.881-885, 2010.
DOI : 10.1002/ajmg.a.33183

C. Kilcline and I. Frieden, Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature, Pediatric Dermatology, vol.86, issue.57, pp.168-73, 2008.
DOI : 10.1016/j.jpeds.2006.12.003

G. Weiss, Y. Confino, and A. Shemer, Cutaneous manifestations in the cardiofaciocutaneous syndrome, a variant of the classical Noonan syndrome. Report of a case and review of the literature, Journal of the European Academy of Dermatology and Venereology, vol.57, issue.3, pp.18324-18331, 2004.
DOI : 10.1002/(SICI)1096-8628(19990115)82:2<187::AID-AJMG17>3.0.CO;2-2

A. Roberts, J. Allanson, and S. Jadico, The cardiofaciocutaneous syndrome, Journal of Medical Genetics, vol.43, issue.11, pp.43833-43875, 2006.
DOI : 10.1136/jmg.2006.042796

E. Legius, D. Marchuk, and F. Collins, Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis, Nature Genetics, vol.7, issue.2, pp.122-128, 1993.
DOI : 10.1128/MCB.11.2.906

L. Kluwe, R. Siebert, and S. Gesk, Screening 500 unselected neurofibromatosis 1 patients for deletions of theNF1 gene, Human Mutation, vol.42, issue.2, pp.111-117, 2004.
DOI : 10.1007/978-3-642-59918-7_9

!. Brems, H. Chmara, M. Sahbatou, and M. , Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1???like phenotype, Nature Genetics, vol.45, issue.9, pp.1120-1126, 2007.
DOI : 10.1074/jbc.C100386200

L. Boon, J. Mulliken, and M. Vikkula, RASA1: variable phenotype with capillary and arteriovenous malformations, Current Opinion in Genetics & Development, vol.15, issue.3, pp.265-274, 2005.
DOI : 10.1016/j.gde.2005.03.004

I. Eerola, L. Boon, and J. Mulliken, Capillary Malformation???Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations, The American Journal of Human Genetics, vol.73, issue.6, pp.731240-731249, 2003.
DOI : 10.1086/379793

N. Revencu, L. Boon, and J. Mulliken, Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations, Hum Mutat, issue.7, pp.29959-65, 2008.

E. Friedman, P. Gejman, and G. Martin, Nonsense mutations in the C???terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours, Nature Genetics, vol.86, issue.3, pp.242-249, 1993.
DOI : 10.1016/0014-5793(89)81618-7

J. Oliveira, N. Bidère, and J. Niemela, NRAS mutation causes a human autoimmune lymphoproliferative syndrome, Proceedings of the National Academy of Sciences, vol.25, issue.4, pp.8953-8961, 2007.
DOI : 10.1006/meth.2001.1262

T. Hart, Y. Zhang, and M. Gorry, A Mutation in the SOS1 Gene Causes Hereditary Gingival Fibromatosis Type 1, The American Journal of Human Genetics, vol.70, issue.4, pp.943-54, 2002.
DOI : 10.1086/339689

D. Luca, A. Bottillo, I. Sarkozy, and A. , NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome, Am J Hum Genet, issue.6, pp.771092-101, 2005.

E. Denayer and E. Legius, What???s new in the neuro-cardio-facial-cutaneous syndromes?, European Journal of Pediatrics, vol.132, issue.11, pp.1661091-1661099, 2007.
DOI : 10.1002/ajmg.a.31658

M. Zenker, K. Lehmann, and A. Schulz, Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations, Journal of Medical Genetics, vol.44, issue.2, pp.131-136, 2007.
DOI : 10.1136/jmg.2006.046300

R. Blomhoff and H. Blomhoff, Overview of retinoid metabolism and function, Journal of Neurobiology, vol.69, issue.144, pp.606-636, 2006.
DOI : 10.1016/S1388-1981(02)00212-3